Definium Therapeutics, Inc. · NASDAQ:DFTX
Adsett Roger received 3,555 Definium Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Adsett Roger (Director) received 3,555 Definium Therapeutics, Inc. shares as an award, leaving 3,555 shares. Filed Jun 15, 2026 (Form 4).
- Awarded
- 3,555 shares
- Holding after
- 3,555 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Shares | Award | 3,555 | 3,555 | Direct |